AnalysisNews

BSX today

$45.13+$0.43 (+0.96%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bullish

1 hourStrong Bullish

15 minAscending Triangle

5 minLeaning Bearish

Daily trend turns up above $46.55

Key levels

Resistance$49.66

Resistance$46.97

Support$42.69

Support$39.57

Latest news & SEC filings

SEC FilingBoston Scientific Corp filed an insider trading report (Form 4)

LegalBronstein, Gewirtz & Grossman opens investigation into Boston Scientific

AnalystCCORF keeps Buy rating and $48 target on Boston Scientific

All BSX news →

About Boston Scientific

Boston Scientific is a medical device maker that develops, produces, and sells devices used in clinical procedures. Its customers are primarily health care providers and clinicians around the world, and a substantial share of sales comes from outside the United States. The company competes across several product areas and invests in research, clinical studies, and regulatory clearances to launch new and improved devices.

Based on the company's 10-K filed Feb 17, 2026.

NYSE · Healthcare

BOSTON SCIENTIFIC CORP (BSX)

$45.13+0.43 (+0.96%)
WATCHLISTGrade: ARisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
42.4743.3544.2445.1245.13Oct 9Oct 19Oct 27Nov 4
High45.82
Low43.87
Open44.06
Volume16.44M
Avg Vol17.73M
VWAP45.24
30d High46.01
30d Low41.58
30d Chg+4.40%

What Is the Price Target for BSX?

SEPT Low Target

$44.00

SEPT Mid Target

$49.50

SEPT High Target

$65.00

Analyst Consensus

$49.50

Current: $45.13Upside: +9.7%Confidence: 85%Method: Analyst Consensus

Is BSX a Buy or Sell Right Now?

78
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Oct 28▼ DownEarningsLeadershipUpgrade5 articles
Boston Scientific shares closed at $42.43, up 1.14% on heavy volume of 64 million shares, despite a mixed news day. The company cut its guidance amid a hacking incident and other headwinds, and an executive flagged that revenue growth will be difficult through 2027 apart from the Penumbra transaction. Needham maintained its Buy rating but lowered its price target to $48, while the company also held its Q3 2026 earnings call and posted results. The guidance cut and cautious 2027 outlook are bearish signals, though the stock's gain suggests investors may be looking past the near-term issues.

Thesis

  • •Revenue growing 19.9% YoY with ACCELERATING trend — accelerating momentum.
  • •Smart money flows are positive — institutional and insider activity shows net buying.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BSX.

Start Free Trial →

Is BSX Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, PEG, Analyst Consensus

Fair Value

$51.37

58

Moat Score

NARROW

7/9

Piotroski Score

N/A

Altman Z-Score

What Is Smart Money Doing with BSX?

Insider Signal

BUYING

4 buys / 0 sells (90d)

Congress Signal

BUYING

7 buys / 13 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Mahoney Michael Fdirector officerBuy149,992-Nov 4, 2026
Mahoney Michael Fdirector officerBuy102,249-Nov 4, 2026
O'Sullivan MiriamofficerBuy3,871-Nov 1, 2026
O'Sullivan MiriamofficerSale1,872$79KNov 1, 2026
Mahoney Michael Fdirector officerSale386,755-May 28, 2026
Pegus CheryldirectorBuy1,770$100KMay 20, 2026
LUDWIG EDWARD JdirectorBuy3,580$203KMay 20, 2026
Habiger David CdirectorBuy2,250$126KMay 20, 2026
Habiger David CdirectorBuy2,200$125KMay 19, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

BSX Growth Story

Revenue YoY

19.9%

3yr Revenue CAGR

16.5%

EPS Growth YoY

55.2%

FCF Growth YoY

38.3%

Revenue Trend

ACCELERATING

Dark Pool Trades for BSX

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for BSX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
24:03:29$45.134,434$$200KSELL
23:43:41$45.131,000$$45KSELL
22:25:52$45.13145,300$$6.6MSELL
21:57:11$45.13632,067$$28.5MSELL
21:28:27$45.1322,599$$1.0MSELL

5 dark pool trades shown · $$36.3M preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for BSX

PREVIEW

SEPT Investing provides real-time options flow tracking for BSX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
PUT$45Jan 1565$$2501SWEEP
PUT$45Jan 1565$$7503SWEEP
PUT$45Jan 1565$$12505SWEEP
PUT$45Jan 1565$$325013SWEEP
PUT$42.5Jan 1565$$540036SWEEP

5 options trades shown · 0% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

What Traders Are Saying About BSX

2 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for BSX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

S
SEPT InvestingVERIFIED110d ago

Zone Setup -- $BSX (BOSTON SCIENTIFIC CORP) Price: $44.27 | Zone: $42.25 to $45.22 Conviction: HIGH | Analyst upside: +59.8% Near resistance (68% of range) — breakout watch. Strong positive news (3+...

80 views
S
SEPT InvestingVERIFIED139d ago

SEPT Brain on $BSX -- Neutral BSX pulling back — down 6% from $47.25. Day range $43.89-$45.28. Last candle: strong bullish close (100% buying). Price in middle of zone $43.89-$45.22 — direction uncle...

362 views

Join 3,500+ traders discussing BSX in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for BOSTON SCIENTIFIC CORP (BSX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

BSX — frequently asked questions

What is BSX stock price today?

BOSTON SCIENTIFIC CORP (BSX) is at $45.13, up 0.96% (+$0.43) at the Nov 11, 2026 close.

Why is BSX stock moving today?

Latest BSX news — Nov 6, 2026: Boston Scientific Corp filed an insider trading report (Form 4) · Nov 6, 2026: Bronstein, Gewirtz & Grossman opens investigation into Boston Scientific

Why did BSX stock move on Oct 28, 2026?

Boston Scientific shares closed at $42.43, up 1.14% on heavy volume of 64 million shares, despite a mixed news day. The company cut its guidance amid a hacking incident and other headwinds, and an executive flagged that revenue growth will be difficult through 2027 apart from the Penumbra transaction.

What is the BSX price target?

The average analyst price target for BSX is $49.50, ranging from $44 to $65, based on 18 analysts. Latest: CCORF maintains on Nov 4, 2026.

What do analysts rate BSX?

Analyst ratings for BSX: 0 Buy, 61 Hold, 10 Sell — consensus Hold.

Did BSX beat earnings?

BSX last reported on Oct 28, 2026: EPS $0.73 vs $0.72 expected — a beat of 1.7%.

What is BSX's P/E ratio?

BSX trades at a P/E of 18.4 vs a Healthcare average of 17.3.

Does BSX pay a dividend?

BSX does not currently pay a dividend.

How much debt does BSX have?

BOSTON SCIENTIFIC CORP reported $10.9B of debt and $609M of cash (Sep 30, 2026).

What are BSX support and resistance levels?

Support: $42.69, $39.57. Resistance: $46.97, $49.66, $52.99.

What are insiders doing with BSX?

Insider activity: BUYING, 4 buys and 0 sells in the last 90 days.

What is the latest news on BSX?

Nov 6, 2026: Boston Scientific Corp filed an insider trading report (Form 4) · Nov 6, 2026: Bronstein, Gewirtz & Grossman opens investigation into Boston Scientific · Nov 4, 2026: CCORF keeps Buy rating and $48 target on Boston Scientific